Govt places new purchase order for 10 crore doses of Covishield Covid-19 vaccine with Serum Institute

Published on Mar 16, 2021 08:30 PM IST

The HLL Lifecare Limited, a public sector undertaking, has issued the supply order on behalf of the Union health ministry on March 12 in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based SII.

The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.(Reuters)
The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.(Reuters)
PTI | , New Delhi

The Centre has placed a new purchase order with the Serum Institute of India (SII) for the supply of 10 crore doses of the Oxford-AstraZeneca Covid-19 vaccine, Covishield, each costing 157.50, including GST, according to official sources.

The HLL Lifecare Limited, a public sector undertaking, has issued the supply order on behalf of the Union health ministry on March 12 in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at the Pune-based SII. 

The cost of the 10 crore doses would be borne by the health ministry under the budgetary allocation for the purpose.

The expenditure for the earlier orders of the vaccines was funded through the PM Cares Fund, the sources said.

India has approved two vaccines against Covid-19 -- Covishield, manufactured by the SII, and the indigenously-developed Covaxin of Bharat Biotech -- for restricted emergency use in the country.

Get Latest India Newsalong with Latest Newsand Top Headlinesfrom India and around the world.
SHARE THIS ARTICLE ON
SHARE
Story Saved
OPEN APP
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Thursday, February 09, 2023
Start 15 Days Free Trial Subscribe Now
Register Free and get Exciting Deals